467 related articles for article (PubMed ID: 19107439)
1. Breast cancer screening and biomarkers.
Brooks M
Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis.
Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516
[TBL] [Abstract][Full Text] [Related]
3. Nuclear matrix proteins as biomarkers for breast cancer.
Lüftner D; Possinger K
Expert Rev Mol Diagn; 2002 Jan; 2(1):23-31. PubMed ID: 11963799
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of four serological tumor markers for the detection of breast cancer.
Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
[TBL] [Abstract][Full Text] [Related]
5. [Biomarkers in breast cancer].
Kurebayashi J
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1021-6. PubMed ID: 15272579
[TBL] [Abstract][Full Text] [Related]
6. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
[TBL] [Abstract][Full Text] [Related]
7. Pathways to personalized medicine for breast and prostate cancers: emerging diagnostic methods and prognostic biomarkers.
Watson AP; Egland KA
S D Med; 2010 Jul; 63(7):247-53. PubMed ID: 20666024
[TBL] [Abstract][Full Text] [Related]
8. Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.
Ambeba E; Linkov F
Future Oncol; 2011 Dec; 7(12):1399-414. PubMed ID: 22112316
[TBL] [Abstract][Full Text] [Related]
9. [Proteome analysis for identification of tumor-associated biomarkers in breast cancer].
Wang X; Liang WJ; Zhu ZY; Yang MT; Zeng YX
Ai Zheng; 2004 Nov; 23(11 Suppl):1577-81. PubMed ID: 15566683
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
[TBL] [Abstract][Full Text] [Related]
11. [Tumor markers in gynecological and breast cancer].
Jobo T; Sato R; Kuramoto H
Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
Zheng H; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
[TBL] [Abstract][Full Text] [Related]
13. Serum proteome profiling of primary breast cancer indicates a specific biomarker profile.
Böhm D; Keller K; Wehrwein N; Lebrecht A; Schmidt M; Kölbl H; Grus FH
Oncol Rep; 2011 Nov; 26(5):1051-6. PubMed ID: 21837365
[TBL] [Abstract][Full Text] [Related]
14. Pooling of case specimens to create standard serum sets for screening cancer biomarkers.
Skates SJ; Horick NK; Moy JM; Minihan AM; Seiden MV; Marks JR; Sluss P; Cramer DW
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):334-41. PubMed ID: 17301268
[TBL] [Abstract][Full Text] [Related]
15. CA 15-3: uses and limitation as a biomarker for breast cancer.
Duffy MJ; Evoy D; McDermott EW
Clin Chim Acta; 2010 Dec; 411(23-24):1869-74. PubMed ID: 20816948
[TBL] [Abstract][Full Text] [Related]
16. A review of novel biological tools used in screening for the early detection of lung cancer.
Ghosal R; Kloer P; Lewis KE
Postgrad Med J; 2009 Jul; 85(1005):358-63. PubMed ID: 19581246
[TBL] [Abstract][Full Text] [Related]
17. The evolving role of proteomics in the early detection of breast cancer.
Pawlik TM; Kuerer HM
Int J Fertil Womens Med; 2005; 50(5 Pt 1):212-6. PubMed ID: 16468471
[TBL] [Abstract][Full Text] [Related]
18. Screening for breast cancer: current recommendations and future directions.
Knutson D; Steiner E
Am Fam Physician; 2007 Jun; 75(11):1660-6. PubMed ID: 17575656
[TBL] [Abstract][Full Text] [Related]
19. Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models.
Hwa HL; Kuo WH; Chang LY; Wang MY; Tung TH; Chang KJ; Hsieh FJ
J Eval Clin Pract; 2008 Apr; 14(2):275-80. PubMed ID: 18284517
[TBL] [Abstract][Full Text] [Related]
20. Screening and diagnosis of breast cancer in augmented women.
Uematsu T
Breast Cancer; 2008; 15(2):159-64. PubMed ID: 18293060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
